RiverVest Venture Management
Latest statistics and disclosures from RiverVest Venture Management's latest quarterly 13F-HR filing:
Tip: Access up to 7 years of quarterly data
Positions held by RiverVest Venture Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for RiverVest Venture Management
RiverVest Venture Management holds 5 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Allakos Common (ALLK) | 50.2 | $14M | 5.0M | 2.73 |
|
|
| Spruce Bioscience Common (SPRB) | 31.7 | $8.6M | 2.9M | 2.93 |
|
|
| Reneo Pharmaceuticals Common (RPHM) | 15.0 | $4.1M | 2.5M | 1.60 |
|
|
| Xilio Therapeutics Common (XLO) | 2.9 | $793k | 1.4M | 0.55 |
|
|
| Vapotherm Common | 0.2 | $53k | 53k | 1.00 |
|
Past Filings by RiverVest Venture Management
SEC 13F filings are viewable for RiverVest Venture Management going back to 2021
- RiverVest Venture Management 2023 Q4 filed Feb. 12, 2024
- RiverVest Venture Management 2023 Q3 filed Oct. 30, 2023
- RiverVest Venture Management 2023 Q2 filed Aug. 7, 2023
- RiverVest Venture Management 2023 Q1 filed April 27, 2023
- RiverVest Venture Management 2022 Q4 filed Feb. 14, 2023
- RiverVest Venture Management 2022 Q3 filed Nov. 14, 2022
- RiverVest Venture Management 2022 Q2 filed Aug. 10, 2022
- RiverVest Venture Management 2022 Q1 filed May 2, 2022
- RiverVest Venture Management 2021 Q4 filed Feb. 7, 2022
- RiverVest Venture Management 2021 Q3 filed Nov. 12, 2021
- RiverVest Venture Management 2021 Q2 filed Aug. 11, 2021
- RiverVest Venture Management 2020 Q4 filed Aug. 11, 2021
- RiverVest Venture Management 2021 Q1 filed Aug. 11, 2021